T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease

被引:19
作者
Tambasco, Nicola [1 ]
Paoletti, Federico Paolini [1 ]
Chiappiniello, Andrea [2 ]
Lisetti, Viviana [3 ]
Nigro, Pasquale [1 ]
Eusebi, Paolo [1 ]
Chiarini, Pietro [4 ]
Romoli, Michele [1 ]
Brahimi, Elona [1 ]
Simoni, Simone [1 ]
Filidei, Marta [1 ]
Floridi, Piero [4 ]
Tarducci, Roberto [5 ]
Parnetti, Lucilla [1 ,3 ]
Calabresi, Paolo [1 ,3 ,6 ]
机构
[1] Univ Perugia, Santa Maria Misericordia Hosp, Neurol Dept, I-06156 Perugia, Italy
[2] Univ Perugia, Phys & Geol Dept, Perugia, Italy
[3] Univ Perugia, Santa Maria Misericordia Hosp, Ctr Memory Disturbances, Lab Clin Neurochem,Sect Neurol Dept, Perugia, Italy
[4] Santa Maria Misericordia Hosp, Radiodiagnost Dept, Neuroradiol Unit, Perugia, Italy
[5] Santa Maria Misericordia Hosp, Med Phys Unit, Perugia, Italy
[6] IRCCS Fdn Santa Lucia, Expt Neurophysiol Lab, Rome, Italy
关键词
Parkinson's disease; Cognitive impairment; Brain iron; Magnetic resonance imaging; Susceptibility-weighted imaging; BRAIN IRON DEPOSITION; DIAGNOSTIC-CRITERIA; SUBSTANTIA-NIGRA; NORMATIVE DATA; IMPAIRMENT; MILD; DEMENTIA; PATTERNS; AGE;
D O I
10.1016/j.neurobiolaging.2019.04.005
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Brain iron load is one of the main neuropathologic hallmarks of Parkinson's disease (PD). Previous studies indicated that iron in the substantia nigra (SN) is related to disease duration and motor impairment. We explore, through a cross-sectional study, the association between brain iron distribution, evaluated by T2*-weighted magnetic resonance imaging (T2*), and clinical features in a cohort of patients with PD. Thirty-two patients with PD, compared with 10 control subjects, were evaluated for motor and cognitive features (attention and working memory, executive functions, language, memory, and visuospatial function). They underwent amagnetic resonance imaging protocol including T2* analysis of specific brain regions of interest to measure iron load compared with healthy control subjects. We found that iron content of the SN correlated positively with both disease duration and Unified Parkinson's Disease Rating Scale III off score. Montreal Cognitive Assessment, Spatial Span, and Graded Naming Test scores were inversely associated with iron load of the SN, whereas Wechsler Adult Intelligence Scale-IV Similarities score showed an inverse relationship with iron content in all the regions of interest examined. Our findings suggest a relationship between topographic brain iron distribution and cognitive domain impairment. (C) 2019 Published by Elsevier Inc.
引用
收藏
页码:91 / 98
页数:8
相关论文
共 50 条
  • [21] How do cognitive and axial motor signs correlate in Parkinson's disease? A 6-year prospective study
    Gago, Miguel Fernandes
    Garrett, M. C.
    Fonseca, M. R.
    Rosas, M. J.
    Simoes, M. F.
    Vieira, S.
    Botelho, F.
    JOURNAL OF NEUROLOGY, 2009, 256 (10) : 1655 - 1662
  • [22] Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson's Disease
    Novak, Kevin
    Chase, Bruce A.
    Narayanan, Jaishree
    Indic, Premananda
    Markopoulou, Katerina
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 13
  • [23] Is fatigue associated with cognitive dysfunction in early Parkinson's disease?
    Kluger, Benzi M.
    Pedersen, Kenn Freddy
    Tysnes, Ole-Bjorn
    Ongre, Solgunn O.
    Oygarden, Bjorg
    Herlofson, Karen
    PARKINSONISM & RELATED DISORDERS, 2017, 37 : 87 - 91
  • [24] Mitochondrial Dysfunction in Parkinson's Disease: A Contribution to Cognitive Impairment?
    Scorziello, Antonella
    Sirabella, Rossana
    Sisalli, Maria Jose
    Tufano, Michele
    Giaccio, Lucia
    D'Apolito, Elena
    Castellano, Lorenzo
    Annunziato, Lucio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (21)
  • [25] Cognitive dysfunction and dementia in Parkinson's disease
    Bosboom, JLW
    Stoffers, D
    Wolters, EC
    JOURNAL OF NEURAL TRANSMISSION, 2004, 111 (10-11) : 1303 - 1315
  • [26] MRI and Cognitive Impairment in Parkinson's Disease
    Ibarretxe-Bilbao, Naroa
    Tolosa, Eduardo
    Junque, Carme
    Marti, Maria-Jose
    MOVEMENT DISORDERS, 2009, 24 (14) : S748 - S753
  • [27] Biomarkers for cognitive dysfunction in Parkinson's disease
    Kalia, Lorraine V.
    PARKINSONISM & RELATED DISORDERS, 2018, 46 : S19 - S23
  • [28] Effects of the Adenosine A2A Receptor Antagonist on Cognitive Dysfunction in Parkinson's Disease
    Uchida, Shin-ichi
    Kadowaki-Horita, Takako
    Kanda, Tomoyuki
    ADENOSINE RECEPTORS IN NEUROLOGY AND PSYCHIATRY, 2014, 119 : 169 - 189
  • [29] T2*MRI of minimal hepatic encephalopathy and cognitive correlates in vivo
    Liu, Jian-Ying
    Ding, Jing
    Lin, Dong
    He, Yi-Feng
    Dai, Zhi
    Chen, Cai-Zhong
    Cheng, Wei-Zhong
    Wang, He
    Zhou, Jian
    Wang, Xin
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2013, 37 (01) : 179 - 186
  • [30] Genomic determinants of motor and cognitive outcomes in Parkinson's disease
    Chung, Sun Ju
    Armasu, Sebastian M.
    Biernacka, Joanna M.
    Anderson, Kari J.
    Lesnick, Timothy G.
    Rider, David N.
    Cunningham, Julie M.
    Ahlskog, J. Eric
    Frigerio, Roberta
    Maraganore, Demetrius M.
    PARKINSONISM & RELATED DISORDERS, 2012, 18 (07) : 881 - 886